Company intelligence / Profile preview
Keltic Pharma Therapeutics
Glasgow, Scotland, UKkeltic-pharma.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Keltic Pharma has developed a novel drug discovery platform, PEPSMOL, targeting previously undruggable GPCRs. Its lead programs include first-in-class inhibitors for malaria (PfCLK3) supported by major grants from the EU Malaria Fund and Gates Foundation. The company is also developing inhaled synthetic biologics for severe asthma and exploring therapies for neurodegeneration. Early-stage results are promising, with over £9.5 million in follow-on research funding secured.
- Therapeutic areas
- PulmonologyImmunologyNeurologyInfectious Diseases
- Modalities
- Synthetic biologics (notably inhaled)Small molecules (via PEPSMOL platform)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
University of Glasgow (founding institution)EU Malaria FundBill & Melinda Gates FoundationMedical Research Council’s Confidence in Concept / Impact Accelerator Accounts
Beyond the preview
Go deeper on Keltic Pharma Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Keltic Pharma Therapeutics.